1-20 of 55
Zhao Wang
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Chronic active Epstein-Barr virus disease originates from infected hematopoietic stem cells

Clinical Trials & Observations
Jingshi Wang, Min Su, Na Wei, Huanyu Yan, Jia Zhang, Yi Gong, Lin Wu, Dina Suolitiken, Yubo Pi, Deli Song, Leilei Chen, Huan Liu, Shuo Yang, Xi Wang, Zhao Wang
Journal: Blood
Blood (2024) 143 (1): 32–41.
https://doi.org/10.1182/blood.2023021074
Published: 2024
Includes: Supplemental data
Journal Articles

The Combination of Iguratimod and Danazol Versus Danazol As a Treatment of Corticosteroid-Resistant/Relapse Immune Thrombocytopenia: A Randomized, Controlled, Multicenter, Open-Label Trial

Xiaolu Zhu, Hui Liu, Zhao Wang, Zhongxing Jiang, Liangming Ma, Min Wang, Jiamin Zhang, Zhuoyu An, Yejun Wu, Yun He, Haixia Fu, Yingjun Chang, Lanping Xu, Kaiyan Liu, Xiao Jun Huang, Xiaohui Zhang
Journal: Blood
Blood (2023) 142 (Supplement 1): 2589.
https://doi.org/10.1182/blood-2023-184342
Published: 2023
Journal Articles

Prophylactic or Preemptive Donor-Derived CD19 CAR-T Cell Infusion for Preventing Relapse in High-Risk B-ALL after Allogeneic Hematopoietic Stem Cell Transplantation

Wenyi Lu, Meng Zhang, Hairong Lv, Xia Xiao, Xue Bai, Jiaxi Wang, Yedi Pu, Juanxia Meng, Xiaomei Zhang, Haibo Zhu, Ting Yuan, Bing Wang, Xin Jin, Xinping Cao, Zhao Wang, Tianle Xie, Haotian Meng, Alexey Stepanov, Alexander G. Gabibov, Yuxin An, Rui Sun, Yu Zhang, Mikhail A. Maschan, Zunmin Zhu, Hongkai Zhang, Mingfeng Zhao
Journal: Blood
Blood (2023) 142 (Supplement 1): 2100.
https://doi.org/10.1182/blood-2023-173926
Published: 2023
Journal Articles

Baricitinib in Combination with High-Dose Dexamethasone As First-Line Treatment for Newly Diagnosed Immune Thrombocytopenia: A Prospective, Multicenter, Randomized Trial

Peng Zhao, Zhuoyu An, Haixia Fu, Daihong Liu, Liping Dou, Yi Liu, Hui Liu, Zhao Wang, Yujun Dong, Hongmei Jing, Hebing Zhou, Zhen-Ling Li, Lihong Li, Qiu-Sha Huang, Jin Wu, Yejun Wu, Chen-Cong Wang, Xiaolu Zhu, Qi Chen, Yun He, Kaiyan Liu, Xiaohui Zhang
Journal: Blood
Blood (2023) 142 (Supplement 1): 1207.
https://doi.org/10.1182/blood-2023-181622
Published: 2023
Journal Articles

Treatments and Outcomes of Lymphoma-Associated Hyperinflammation- a Report from the HLH in Adults Working Group for the Histiocyte Society

Adi Zoref-Lorenz, Swami P. Iyer, Jun Murakami, Liron Hofstetter, Rishab Prakash, Shiri Weinstein, Joanne Yacobovich, Shai Izraeli, Sarah Nikiforow, Ronit Gurion, Inbar Cohen, Pia Raanani, Arnon Nagler, Nancy Berliner, Martin H. Ellis, Gilad Itchaki, Michael B. Jordan, David Pottinger, Jerome Razanamahery, Zhao Wang, Gaurav Goyal
Journal: Blood
Blood (2023) 142 (Supplement 1): 2537.
https://doi.org/10.1182/blood-2023-188829
Published: 2023
Journal Articles

A Phase Ib Open-Label Study of MRG001 in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma (R/R DLBCL)

Jun Zhu, Yuqin Song, Ye Guo, Keshu Zhou, Wenyu Li, Yu Yang, Qingqing Cai, Zhao Wang, Haiyan Yang
Journal: Blood
Blood (2023) 142 (Supplement 1): 3089.
https://doi.org/10.1182/blood-2023-189675
Published: 2023
Journal Articles

Biomarker MSC-C5b-9-Guided Master Therapies for Resistant/Recurrent ITP: A Prospective, Randomized, Open-Label, Multicenter Trial

Menglin Li, Haixia Fu, Yi Liu, Hui Liu, Ru Feng, Zhao Wang, Jingwen Wang, Yuxiu Chen, Qingyuan Qu, Mengyu Xiao, Jianying Zhou, Yun He, Xiaolu Zhu, Yuan Kong, Yingjun Chang, Kaiyan Liu, Xiaohui Zhang
Journal: Blood
Blood (2023) 142 (Supplement 1): 3951.
https://doi.org/10.1182/blood-2023-182669
Published: 2023
Journal Articles

A Phase I Clinical Trial of CLL-1 CAR-T Cells for the Treatment of Relapsed/Refractory Acute Myeloid Leukemia in Adults

Xiaomei Zhang, Hairong Lv, Xia Xiao, Xue Bai, Pengjiang Liu, Yedi Pu, Juanxia Meng, Haibo Zhu, Zhao Wang, Huan Zhang, Yu Zhang, Cuicui Lv, Li Ma, Ting Yuan, Meng Zhang, Rui Sun, Yifan Zhao, Xinping Cao, Ruiting Guo, Yi Zhang, Shujing Guo, Jile Liu, Mingfeng Zhao
Journal: Blood
Blood (2023) 142 (Supplement 1): 2106.
https://doi.org/10.1182/blood-2023-180387
Published: 2023
Journal Articles

Caebv Disease Originates from Infected Hematopoietic Stem Cells

Jingshi Wang, Na Wei, Jia Zhang, Lin Wu, Xi Wang, Zhao Wang
Journal: Blood
Blood (2023) 142 (Supplement 1): 1175.
https://doi.org/10.1182/blood-2023-173226
Published: 2023
Journal Articles

Alterations of Gut Microbiota in Myelodysplastic Syndromes and Aplastic Anemia: Potential Relationship with Inflammatory Response

Wanshu Chen, Bing Han, Zhao Wang
Journal: Blood
Blood (2022) 140 (Supplement 1): 4062.
https://doi.org/10.1182/blood-2022-164635
Published: 2022
Journal Articles

Preliminary Safety and Efficacy of Zanubrutinib in Combination with Lenalidomide in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma

Huilai Zhang, Keshu Zhou, Ying Cheng, Liling Zhang, Haiyan Yang, Liqun Zou, Junning Cao, Huiqiang Huang, Ye Guo, Zhao Wang, Sha Huang, Zhiyu Liang, Hui Yao, Haiyi Guo, Yiqian Fang, Hongjie Zhu
Journal: Blood
Blood (2022) 140 (Supplement 1): 3750–3752.
https://doi.org/10.1182/blood-2022-155979
Published: 2022
Journal Articles

A Dose Escalation Phase Ia Study of Anti-CD20 Antibody Drug Conjugate, MRG001 in Relapsed/Refractory Advanced Non-Hodgkin Lymphom

Yuqin Song, Ye Guo, Zhao Wang, Meng Wu, Wei Peng, Lei Sun, Jinghui Sun, Maggie Li, Jun Zhu
Journal: Blood
Blood (2021) 138 (Supplement 1): 2490.
https://doi.org/10.1182/blood-2021-144829
Published: 2021
Journal Articles

Efficacy and Safety of Recombinant Human-Mouse Chimeric Anti-CD20 Monoclonal Antibody (SCT400) Combined with CHOP in Patients with Treatment-Naïve Diffuse Large B-Cell Lymphoma: A Multicenter, Randomized, Single-Blind, Parallel Active-Controlled, Phase III Study

Yuankai Shi, QingYuan Zhang, Xiaonan Hong, Zhen Wang, Yuhuan Gao, Liqun Zou, Hong Cen, Lin Gui, Yufu Li, Jifeng Feng, Zhao Wang, Mingzhi Zhang, Chuan Jin, Weihua Zhang, Jianda Hu, Chengyun Zheng, Zhendong Zheng, Liling Zhang, Shaoshui Chen, Yunhong Huang, Yun Tang, Yajie Gao, Miaowang Hao, Xiaoling Li, Chunkang Chang, Haiyan Yang, Hui Wu, Lida Shen, Xiaoyan Ke, Liangming Zhang, Yaming Xi, Linhua Yang, Liangzhi Xie
Journal: Blood
Blood (2021) 138 (Supplement 1): 2480.
https://doi.org/10.1182/blood-2021-149861
Published: 2021
Journal Articles

Dose of Deferasirox Correlates with Effects but Is Different in Low-Risk Myelodysplastic Syndrome and Aplastic Anemia

Ruoxi Zhang, Zhao Wang, Bing Han
Journal: Blood
Blood (2021) 138 (Supplement 1): 3075.
https://doi.org/10.1182/blood-2021-145270
Published: 2021
Journal Articles

Recombinant Human Thrombopoietin Accelerates the Recovery of Platelet in Patients with Lower-Risk Myelodysplastic Syndrome: A Prospective Cohort Study

Yuan Yang, Zhao Wang, Bing Han
Journal: Blood
Blood (2021) 138 (Supplement 1): 1525.
https://doi.org/10.1182/blood-2021-146745
Published: 2021
Journal Articles

Relmacabtagene Autoleucel CD19 CART Therapy for Adults with Heavily-Pretreated Relapsed/Refractory Large B-Cell Lymphoma in China

Yuqin Song, Zhitao Ying, Haiyan Yang, Ye Guo, Wenyu Li, Dehui Zou, Daobin Zhou, Zhao Wang, Mingzhi Zhang, Jianqiu Wu, Hui Liu, Pian Zhang, Su Yang, Zisong Zhou, Hongxia Zheng, Jun Zhu
Journal: Blood
Blood (2021) 138 (Supplement 1): 3557.
https://doi.org/10.1182/blood-2021-148358
Published: 2021
Journal Articles

The Type II Glycoengineered Humanized Anti-CD20 Monoclonal Antibody MIL62 Combined with Lenalidomide in Chinese Patients with Relapsed/Refractory Follicular Lymphoma and Marginal Zone Lymphoma: Results of a Multicenter, Single-Arm, Phase 1b/2 Trial

Yuankai Shi, Yan Qin, Yongping Song, Keshu Zhou, Hui Zhou, Hongmei Jing, Ying Xiang, Zhao Wang, Zhen Wang, Aimin Zang, Ou Bai, Zhenyu Li, Huilai Zhang
Journal: Blood
Blood (2021) 138 (Supplement 1): 1351.
https://doi.org/10.1182/blood-2021-146440
Published: 2021
Journal Articles

Plasma Lipidome Acts As Diagnostic Marker and Predictor for Cyclosporin Response in Patients with Aplastic Anemia

Jing Ruan, Bing Han, Zhao Wang, Chen Yang, Yali Du, Miao Chen
Journal: Blood
Blood (2021) 138 (Supplement 1): 2199.
https://doi.org/10.1182/blood-2021-145843
Published: 2021
Journal Articles

Efficacy and Safety of Eltrombopag with or without Immunosuppressant in Patients with Relapsed/Refractory Acquired Aplastic Anemia: A Real-World Experience

Jiang Ji, Ziqi Wan, Jing Ruan, Yali Du, Miao Chen, Chen Yang, Zhao Wang, Bing Han
Journal: Blood
Blood (2021) 138 (Supplement 1): 1124.
https://doi.org/10.1182/blood-2021-145549
Published: 2021
Journal Articles

Clinical Response of CD19 CAR-T Cells (relmacabtagene autoleucel, relma-cel) in Adults with Heavily-Pre-Treated Relapsed/Refractory (r/r) Large B-Cell Lymphoma in China

Jun Zhu, MD, Zhitao Ying, MD, Yuqin Song, MD PhD, Haiyan Yang, MD PhD, Ye Guo, MD, Wenyu Li, PhD, Dehui Zou, MD, Daobin Zhou, MD PhD, Zhao Wang, MD, Mingzhi Zhang, MD, Jianqiu Wu, MD, Hui Liu, MD, Pian Zhang, Su Yang, Zisong Zhou, Hongxia Zheng, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 39–40.
https://doi.org/10.1182/blood-2020-136038
Published: 2020